retatrutide clinical trials retatrutide mechanism A new weight-loss drug called is generating excitement after trial participants lost an average of 30% of their body weight, results that rival or even exceed weight-loss surgery. Researchers also ๐ A triple-action once-weekly injection
Description
SeekPeptides members get access to detailed female-specific protocols, dosing calculators, and updated guidance as the Phase 3 data continues to mature
We talked about the same thing we talked about last year (safe sharps disposal for GLP-1 patients) except this time I had data to back up everything that surprised me the first time around

31 Making strength training feel approachable is key to long-term adherence
Available from: Kornelius E, Huang JY, Lo SC, Huang CN, Yang YS

1 GLP-1 adoption is still rising fast in the US and users remain under treatment Gallup recently published a survey on the share of US adults currently taking GLP-1 drugs for weight loss (excluding those using them for diabetes, which helps explain the slightly lower figure compared to other benchmarks)
